Insider Trading & Ownership of Anthony Gregg Lapointe

Location
Gaithersburg, MD
Summary
The estimated net worth of Anthony Gregg Lapointe is at least $238,250 dollars as of 23 Jan 2026. Anthony Gregg Lapointe is the Director of RIGEL PHARMACEUTICALS INC and owns shares of RIGEL PHARMACEUTICALS INC (RIGL) stock worth about $238.2K.
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Gregg Lapointe
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Anthony Gregg Lapointe and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • Anthony Gregg Lapointe has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $238,250.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: RIGEL PHARMACEUTICALS INC ($238,250).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Anthony Gregg Lapointe

SNGX Forms 3/4/5

SOLIGENIX, INC.

Relationship
Director
Holdings value
Past year net change
Change %
Report period
20 Jun 2025

Insider Transactions Reported by Anthony Gregg Lapointe:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .